THE REGENERATIVE INDUSTRY GUIDE
• Aastrom Biosciences, Inc.
“Developing hope… with regenerative therapy”
Committed to helping people with severe, chronic cardiovascular diseases with patient-specific, expanded multicellular therapy. Aastrom is developing ixmyelocel-T therapy from proprietary technology to treat patients with severe, chronic cardiovascular diseases, including dilated cardiomyopathy (DCM).
Aastrom Biosciences, Inc.
Domino’s Farms, Lobby K
24 Frank Lloyd Wright Drive
Ann Arbor, MI 48105
www.aastrom.com
Phone: (734) 418-4400 or (888) 556-0311
Fax: (734) 665-0485
Email: mail@aastrom.com
Mailing Address
Aastrom Biosciences, Inc.
P.O. Box 376
Ann Arbor, MI 48106
••
BioHeart, Inc.
“Advancing Regenerative Medicine Solutions”
Founded in 1999, Bioheart, Inc. is committed to the development of effective cell technologies to treat cardiovascular diseases. Unlike other organs, the human heart does not have the ability to repair itself once it is damaged. Bioheart’s discoveries include multiple cell therapies in various stages of development that repair damaged hearts of patients suffering from chronic and acute heart damage. Bioheart is focused solely on the treatment of cardiovascular related diseases.
Bioheart, Inc.
13794 NW 4th Street, Suite 212
Sunrise, Florida 33325
www.bioheartinc.coM
Telephone: (954)-835-1500
Fax: (954)-845-9976
bioheart@bioheartinc.com
Blog: stemcellceo/wp/bioheart/